Stemtech Corp (STEK) EBT Margin (2021 - 2026)

Stemtech (STEK) posted EBT Margin of 270.63% for Q1 2026, up 16.36% sequentially from 323.57% in Q4 2025, and down 10258.0% YoY from N/an in Q1 2025.

Stemtech Corp (STEK) EBT Margin (2021 - 2026) Analysis & Trends

Stemtech has reported EBT Margin for 6 years, with the latest figure at 270.63% in Q1 2026.

Quarterly EBT Margin fell 10258.0% year-over-year to 270.63% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 155.55% (down 7159.0% YoY) and the FY2025 annual result came in at 140.8%, down 6614.0% from the prior year.
EBT Margin rose to 270.63% in Q1 2026 per STEK's latest filing, from 323.57% in the prior quarter.
Over five years, EBT Margin peaked at 1660.53% in Q3 2022 and troughed at 1956.08% in Q2 2022.
A 5-year average of 119.24% and a median of 95.34% in 2025 frame the typical range for EBT Margin.
The widest YoY moves for EBT Margin: up 224649 bps in 2022, down 188065 bps in 2022.
Over 5 years, EBT Margin stood at 41.32% in 2022, then slumped by 231 bps to 136.88% in 2023, then jumped by 78 bps to 30.19% in 2024, then sank by 972 bps to 323.57% in 2025, then gained by 16 bps to 270.63% in 2026.
According to Business Quant data, EBT Margin over the past three periods registered 270.63%, 323.57%, and 95.34% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Download Data